nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

22.03.2019 | Review – Cancer Research

Controlling metastatic cancer: the role of phytochemicals in cell signaling

verfasst von: Andrea Kapinova, Peter Kubatka, Alena Liskova, Denis Baranenko, Peter Kruzliak, Milan Matta, Dietrich Büsselberg, Bibiana Malicherova, Anthony Zulli, Taeg Kyu Kwon, Eva Jezkova, Dana Blahutova, Pavol Zubor, Jan Danko

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cancer is a serious health issue and a leading cause of death worldwide. Most of the cancer patients (approximately 90%) do not die from the consequences of the primary tumor development, but due to a heavily treatable metastatic invasion. During the lengthy multistep process of carcinogenesis, there are a lot of opportunities available to reverse or slow down the tissue invasion or the process of tumor metastasis formation.

Results

Current research has brought many promising results from anti-metastatic experimental studies, and has shown that chemoprevention by natural or semisynthetic phytochemicals with plethora of biological activities could be one of the potentially effective options in the fight against this problem. However, there is a lack of clinical trials to confirm these findings. In this review, we focused on summarization and discussion of the general features of metastatic cancer, and recent preclinical and clinical studies dealing with anti-metastatic potential of various plant-derived compounds.

Conclusions

Based on our findings, we can conclude and confirm our hypothesis that phytochemicals with pleiotropic anticancer effects can be very useful in retarding and/or reversing the metastasis process, and can also be used to prevent tissue invasion and metastases. But, further studies in this area are certainly necessary and desirable.

Afrin S, Giampieri F, Gasparrini M, Forbes-Hernández TY, Cianciosi D, Reboredo-Rodriguez P, Zhang J, Manna PP, Daglia M, Atanasov AG, Battino M (2018a) Dietary phytochemicals in colorectal cancer prevention and treatment: a focus on the molecular mechanisms involved. Biotechnol Adv. https://doi.org/10.1016/j.biotechadv.2018.11.011 (Epub ahead of print) CrossRefPubMed

Afrin S, Giampieri F, Gasparrini M, Forbes-Hernández TY, Cianciosi D, Reboredo-Rodriguez P, Manna PP, Zhang J, Quiles JL, Battino M (2018b) The inhibitory effect of Manuka honey on human colon cancer HCT-116 and LoVo cell growth. Part 2: induction of oxidative stress, alteration of mitochondrial respiration and glycolysis, and suppression of metastatic ability. Food Funct 9(4):2158–2170. https://doi.org/10.1039/c8fo00165k CrossRefPubMed

Afrin S, Giampieri F, Forbes-Hernández TY, Gasparrini M, Amici A, Cianciosi D, Quiles JL, Battino M (2018c) Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability. Free Radic Biol Med 126:41–54. https://doi.org/10.1016/j.freeradbiomed.2018.07.014 (Epub 2018 Jul 26) CrossRefPubMed

Ahire V, Kumar A, Mishra KP, Kulkarni G (2017) Ellagic acid enhances apoptotic sensitivity of breast cancer cells to γ-radiation. Nutr Cancer 69(6):904–910. https://doi.org/10.1080/01635581.2017.1339811 (Epub 2017 Jul 18) CrossRefPubMed

Al Aameri RFH, Sheth S, Alanisi EMA, Borse V, Mukherjea D, Rybak LP, Ramkumar V (2017) Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. PLoS One 12(5):e0177198. https://doi.org/10.1371/journal.pone.0177198 (eCollection 2017) CrossRefPubMedPubMedCentral

Aryappalli P, Al-Qubaisi SS, Attoub S, George JA, Arafat K, Ramadi KB, Mohamed YA, Al-Dhaheri MM, Al-Sbiei A, Fernandez-Cabezudo MJ, Al-Ramadi BK (2017) The IL-6/STAT3 signaling pathway is an early target of manuka honey-induced suppression of human breast cancer cells. Front Oncol 7:167. https://doi.org/10.3389/fonc.2017.00167 (eCollection 2017) CrossRefPubMedPubMedCentral

Awan HM, Shah A, Rashid F, Shan G (2017) Primate-specific long non-coding RNAs and MicroRNAs. Genomics Proteom Bioinf 15(3):187–195. https://doi.org/10.1016/j.gpb.2017.04.002 (Epub 2017 Jun 8) CrossRef

Baena Ruiz R, Salinas Hernández P (2016) Cancer chemoprevention by dietary phytochemicals: epidemiological evidence. Maturitas 94:13–19. https://doi.org/10.1016/j.maturitas.2016.08.004 (Epub 2016 Aug 18) CrossRefPubMed

Banyard J, Bielenberg DR (2015) The role of EMT and MET in cancer dissemination. Connect Tissue Res 56(5):403–413. https://doi.org/10.3109/03008207.2015.1060970 (Epub 2015 Aug 20) CrossRefPubMedPubMedCentral

Battino M, Forbes-Hernández TY, Gasparrini M, Afrin S, Cianciosi D, Zhang J, Manna PP, Reboredo-Rodríguez P, Varela Lopez A, Quiles JL, Mezzetti B, Bompadre S, Xiao J, Giampieri F (2018) Relevance of functional foods in the Mediterranean diet: the role of olive oil, berries and honey in the prevention of cancer and cardiovascular diseases. Crit Rev Food Sci Nutr 13:1–28. https://doi.org/10.1080/10408398.2018.1526165 (Epub ahead of print) CrossRef

Bhagwandin VJ, Bishop JM, Wright WE, Shay JW (2016) The metastatic potential and chemoresistance of human pancreatic cancer stem cells. PLoS One 11(2):e0148807. https://doi.org/10.1371/journal.pone.0148807 (eCollection 2016) CrossRefPubMedPubMedCentral

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A et al (2015) Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol 35(Suppl):S276–S304. https://doi.org/10.1016/j.semcancer.2015.09.007 CrossRefPubMedPubMedCentral

Bubnov R, Polivka J Jr, Zubor P, Koniczka K, Golubnitschaja O (2017) Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question. EPMA J 8(2):141–157CrossRefPubMedPubMedCentral

Callaghan R, Luk F, Bebawy M (2014) Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos 42(4):623–631. https://doi.org/10.1124/dmd.113.056176 (Epub 2014 Feb 3) CrossRefPubMedPubMedCentral

Cao HH, Chu JH, Kwan HY, Su T, Yu H, Cheng CY, Fu XQ, Guo H, Li T, Tse AK, Chou GX, Mo HB, Yu ZL (2016) Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci Rep 6:21731. https://doi.org/10.1038/srep21731 CrossRefPubMedPubMedCentral

Cătană CS, Atanasov AG, Berindan-Neagoe I (2018) Natural products with anti-aging potential: affected targets and molecular mechanisms. Biotechnol Adv 36(6):1649–1656. https://doi.org/10.1016/j.biotechadv.2018.03.012 CrossRefPubMed

Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Can Res 66:11271–11278CrossRef

Chang HP, Sheen LY, Lei YP (2015a) The protective role of carotenoids and polyphenols in patients with head and neck cancer. J Chin Med Assoc 78(2):89–95. https://doi.org/10.1016/j.jcma.2014.08.010 (Epub 2014 Oct 11) CrossRefPubMed

Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y (2015b) Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance. Crit Rev Oncol Hematol 96(3):507–517. https://doi.org/10.1016/j.critrevonc.2015.07.005 CrossRefPubMed

Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, Bromberg J (2013) The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia 15(7):848–862CrossRefPubMedPubMedCentral

Chen HY, Yang CM, Chen JY, Yueh TC, Hu ML (2015a) Multicarotenoids at physiological levels inhibit metastasis in human hepatocarcinoma SK-Hep-1 cells. Nutr Cancer 67(4):676–686. https://doi.org/10.1080/01635581.2015.1019633 (Epub 2015 Apr 14) CrossRefPubMed

Chen HY, Yang CM, Chen JY, Yueh TC, Hu ML (2015b) Multicarotenoids at physiological levels inhibit metastasis in human hepatocarcinoma SK-Hep-1 cells. Nutr Cancer 67(4):676–686. https://doi.org/10.1080/01635581.2015.1019633 (Epub 2015 Apr 14) CrossRefPubMed

Choi YK, Cho SG, Woo SM, Yun YJ, Park S, Shin YC, Ko SG (2014) Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling. Mediat Inflamm 2014:492173. https://doi.org/10.1155/2014/492173 (Epub 2014 May 25) CrossRef

Chou YS, Yang MH (2015) Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy. J Chin Med Assoc 78:438–445. https://doi.org/10.1016/j.jcma.2015.05.002 CrossRefPubMed

Cianciosi D, Varela-Lopez A, Forbes-Hernandez TY, Gasparrini M, Afrin S, Reboredo-Rodriguez P, Zhang J, Quiles JL, Nabavi SF, Battino M, Giampieri F (2018) Targeting molecular pathways in cancer stem cells by natural bioactive compounds. Pharmacol Res 135:150–165. https://doi.org/10.1016/j.phrs.2018.08.006 (Epub 2018 Aug 10) CrossRefPubMed

Clark AG, Vignjevic DM (2015) Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol 36:13–22. https://doi.org/10.1016/j.ceb.2015.06.004. Epub 2015 Jul 14CrossRefPubMed

Clark AR, Toker A (2014) Signalling specificity in the Akt pathway in breast cancer. Biochem Soc Trans 42(5):1349–1355. https://doi.org/10.1042/BST20140160 CrossRefPubMed

Dasgupta A, Lim AR, Ghajar CM (2017) Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol 11(1):40–61. https://doi.org/10.1002/1878-0261.12022 CrossRefPubMedPubMedCentral

De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13(2):97–110. https://doi.org/10.1038/nrc3447 CrossRefPubMed

Dhar S, Kumar A, Li K, Tzivion G, Levenson AS (2015) Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochim Biophys Acta 1853(2):265–275. https://doi.org/10.1016/j.bbamcr.2014.11.004 (Epub 2014 Nov 13) CrossRefPubMed

Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M (2015) Therapies targeting cancer stem cells: current trends and future challenges. World J Stem Cells 7(9):1185–1201. https://doi.org/10.4252/wjsc.v7.i9.1185 CrossRefPubMedPubMedCentral

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015; 35(Suppl):S25–S54. https://doi.org/10.1016/j.semcancer.2015.02.006 (Epub 2015 Apr 17) CrossRefPubMedPubMedCentral

Fesler A, Guo S, Liu H, Wu N, Ju J (2017) Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer. Epigenomics 9(6):793–796. https://doi.org/10.2217/epi-2017-0041 (Epub 2017 May 18) CrossRefPubMed

Franco AT, Corken A, Ware J (2015) Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126(5):582–588. https://doi.org/10.1182/blood-2014-08-531582 (Epub 2015 Jun 24) CrossRefPubMedPubMedCentral

Ghajar CM (2015) Metastasis prevention by targeting the dormant niche. Nat Rev Cancer 15:238–247. https://doi.org/10.1038/nrc3910 CrossRefPubMedPubMedCentral

Giampieri F, Afrin S, Forbes-Hernandez TY, Gasparrini M, Cianciosi D, Reboredo-Rodriguez P, Varela-Lopez A, Quiles JL, Battino M (2019) Autophagy in human health and disease: novel therapeutic opportunities. Antioxid Redox Signal 30(4):577–634. https://doi.org/10.1089/ars.2017.7234 (Epub 2018 Aug 10) CrossRefPubMed

Giampieri F, Gasparrini M, Forbes-Hernandez TY, Mazzoni L, Capocasa F, Sabbadini S, Alvarez-Suarez JM, Afrin S, Rosati C, Pandolfini T, Molesini B, Sánchez-Sevilla JF, Amaya I, Mezzetti B, Battino M (2018) Overexpression of the anthocyanidin synthase gene in strawberry enhances antioxidant capacity and cytotoxic effects on human hepatic cancer cells. J Agric Food Chem 66(3):581–592. https://doi.org/10.1021/acs.jafc.7b04177 (Epub 2018 Jan 8) CrossRefPubMed

Gkountela S, Szczerba B, Donato C, Aceto N (2016) Recent advances in the biology of human circulating tumour cells and metastasis. ESMO Open 1:e000078CrossRefPubMedPubMedCentral

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, Krapfenbauer K, Mozaffari M, Costigliola V (2016) Medicine in the early twenty-first century: paradigm and anticipation—EPMA position paper 2016. EPMA J 7:23CrossRefPubMedPubMedCentral

Guan F, Ding Y, Zhang Y, Zhou Y, Li M, Wang C (2016) Curcumin suppresses proliferation and migration of MDA-MB-231 breast cancer cells through autophagy-dependent Akt degradation. PLoS One 11(1):e0146553. https://doi.org/10.1371/journal.pone.0146553 (eCollection 2016) CrossRefPubMedPubMedCentral

Gulei D, Mehterov N, Nabavi SM, Atanasov AG, Berindan-Neagoe I (2018) Targeting ncRNAs by plant secondary metabolites: the ncRNAs game in the balance towards malignancy inhibition. Biotechnol Adv 36(6):1779–1799. https://doi.org/10.1016/j.biotechadv.2017.11.003 CrossRefPubMed

Guo Y, Su ZY, Kong AN (2015) Current perspectives on epigenetic modifications by dietary chemopreventive and herbal phytochemicals. Curr Pharmacol Rep 1(4):245–257CrossRefPubMedPubMedCentral

Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL et al (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464:1071–1076CrossRefPubMedPubMedCentral

Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M et al (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73:1180–1189CrossRefPubMed

Ham SL, Nasrollahi S, Shah KN, Soltisz A, Paruchuri S, Yun YH, Luker GD, Bishayee A, Tavana H (2015) Phytochemicals potently inhibit migration of metastatic breast cancer cells. Integr Biol (Camb) 7(7):792–800. https://doi.org/10.1039/c5ib00121h CrossRef

Hamilton G, Rath B (2017a) Circulating tumor cell interactions with macrophages: implications for biology and treatment. Transl Lung Cancer Res 6:418–430. https://doi.org/10.21037/tlcr.2017.07.04 CrossRefPubMedPubMedCentral

Hamilton G, Rath B (2017b) Mesenchymal-epithelial transition and circulating tumor cells in small cell lung cancer. Adv Exp Med Biol 994:229–245. https://doi.org/10.1007/978-3-319-55947-6_12 CrossRefPubMed

Han B, Jiang P, Liu W, Xu H, Li Y, Li Z, Ma H, Yu Y, Li X, Ye X (2018) Role of daucosterol linoleate on breast cancer: studies on apoptosis and metastasis. J Agric Food Chem 66(24):6031–6041. https://doi.org/10.1021/acs.jafc.8b01387 CrossRefPubMed

Hosseini A, Ghorbani A (2015) Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed 5(2):84–97PubMedPubMedCentral

http://www.who.int/news-room/fact-sheets/detail/cancer

Huang Q, Yu H, Ru Q (2010a) Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci 75(1):R50–R57. https://doi.org/10.1111/j.1750-3841.2009.01457.x CrossRefPubMed

Huang Q, Yu H, Ru Q (2010b) Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci 75:R50–R57. https://doi.org/10.1111/j.1750-3841.2009.01457.x CrossRefPubMed

Huang YT, Lan Q, Lorusso G, Duffey N, Rüegg C (2017) The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis. Oncotarget 8(6):9200–9215. https://doi.org/10.18632/oncotarget.13677 CrossRefPubMed

Hyun HB, Moon JY, Cho SK (2018) Quercetin suppresses CYR61-mediated multidrug resistance in human gastric adenocarcinoma AGS cells. Molecules. https://doi.org/10.3390/molecules23020209 CrossRefPubMedPubMedCentral

Jabłońska-Trypuć A, Matejczyk M, Rosochacki S (2016) Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem 31(sup1):177–183 (Epub 2016 Mar 30) CrossRefPubMed

Jafari SM, McClements DJ (2017) Nanotechnology approaches for increasing nutrient bioavailability. Adv Food Nutr Res 81:1–30. https://doi.org/10.1016/bs.afnr.2016.12.008 CrossRefPubMed

Ji Y, Jia L, Zhang Y, Xing Y, Wu X, Zhao B, Zhang D, Xu X, Qiao X (2018) Antitumor activity of the plant extract morin in tongue squamous cell carcinoma cells. Oncol Rep 40(5):3024–3032. https://doi.org/10.3892/or.2018.6650 (Epub 2018 Aug 17) CrossRefPubMed

Jia H, Yang Q, Wang T, Cao Y, Jiang QY, Ma HD, Sun HW, Hou MX, Yang YP, Feng F (2016) Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. Biochim Biophys Acta 1860(7):1417–1430. https://doi.org/10.1016/j.bbagen.2016.04.007 (Epub 2016 Apr 14) CrossRefPubMed

Jia L, Li Z, Shen J, Zheng D, Tian X, Guo H, Chang P (2015) Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. Int J Pharm 489(1–2):318–330. https://doi.org/10.1016/j.ijpharm.2015.05.010 (Epub 2015 May 5) CrossRefPubMed

Jiang M, Zhang R, Wang Y, Jing W, Liu Y, Ma Y, Sun B, Wang M, Chen P, Liu H, He Z (2017a) Reduction-sensitive paclitaxel prodrug self-assembled nanoparticles with tetrandrine effectively promote synergistic therapy against drug-sensitive and multidrug-resistant breast cancer. Mol Pharm 14(11):3628–3635. https://doi.org/10.1021/acs.molpharmaceut.7b00381 (Epub 2017 Sep 27) CrossRefPubMed

Jiang X, Zhu X, Huang W, Xu H, Zhao Z, Li S, Li S, Cai J, Cao J (2017b) Garlic-derived organosulfur compound exerts antitumor efficacy via activation of MAPK pathway and modulation of cytokines in SGC-7901 tumor-bearing mice. Int Immunopharmacol 48:135–145. https://doi.org/10.1016/j.intimp.2017.05.004 (Epub 2017 May 11) CrossRefPubMed

Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, Prince M, Thompson SK, Zollo M, Spano D, Dhawan P et al (2015) Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Semin Cancer Biol 35(Suppl):S244–S275. https://doi.org/10.1016/j.semcancer.2015.03.008 (Epub 2015 Apr 10) CrossRefPubMed

Jin K, Li T, van Dam H, Zhou F, Zhang L (2017a) Molecular insights into tumour metastasis: tracing the dominant events. J Pathol 241(5):567–577. https://doi.org/10.1002/path.4871 (Epub 2017 Mar 7) CrossRefPubMed

Jin K, Li T, van Dam H, Zhou F, Zhang L (2017b) Molecular insights into tumour metastasis: tracing the dominant events. J Pathol 241:567–577. https://doi.org/10.1002/path.4871 CrossRefPubMed

Johnson DE, O’Keefe RA, Grandis JR (2018) Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234–248. https://doi.org/10.1038/nrclinonc.2018.8 (Epub 2018 Feb 6) CrossRefPubMedPubMedCentral

Joshi P, Vishwakarma RA, Bharate SB (2017) Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer. Eur J Med Chem 138:273–292. https://doi.org/10.1016/j.ejmech.2017.06.047 (Epub 2017 Jun 27) CrossRefPubMed

Kala R, Shah HN, Martin SL, Tollefsbol TO (2015) Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer. BMC Cancer 15:672CrossRefPubMedPubMedCentral

Kang Y, Pantel K (2013) Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 23(5):573–581. https://doi.org/10.1016/j.ccr.2013.04.017 CrossRefPubMedPubMedCentral

Kim B, Park B (2018) Saffron carotenoids inhibit STAT3 activation and promote apoptotic progression in IL-6-stimulated liver cancer cells. Oncol Rep 39(4):1883–1891. https://doi.org/10.3892/or.2018.6232 (Epub 2018 Jan 25) CrossRefPubMed

Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edn). Autophagy. 2016;12(1):1–222. https://doi.org/10.1080/15548627.2015.1100356 CrossRefPubMedPubMedCentral

Ko YS, Jin H, Lee JS, Park SW, Chang KC, Kang KM, Jeong BK, Kim HJ (2018) Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells. Oncol Rep. https://doi.org/10.3892/or.2018.6714 (Epub ahead of print) CrossRefPubMed

Koo J, Cabarcas-Petroski S, Petrie JL, Diette N, White RJ, Schramm L (2015) Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein. BMC Cancer 15:905. https://doi.org/10.1186/s12885-015-1914-5 CrossRefPubMedPubMedCentral

Kopp HG, Placke T, Salih HR (2009) Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 69(19):7775–7783. https://doi.org/10.1158/0008-5472.CAN-09-2123 (Epub 2009 Sep 8) CrossRefPubMed

Kotecha R, Takami A, Espinoza JL (2016) Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7(32):52517–52529. https://doi.org/10.18632/oncotarget.9593 CrossRefPubMedPubMedCentral

Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, Sommerhoff CP, Noonan DM, Nerlich AG, Fontana L, Bachmeier BE (2014) miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol 8(3):581–595. https://doi.org/10.1016/j.molonc.2014.01.005 (Epub 2014 Jan 16) CrossRefPubMedPubMedCentral

Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Mojžiš J, Adamkov M, Fialová S, Veizerová L, Zulli A, Péč M, Statelová D, Grančai D, Büsselberg D (2017a) Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Eur J Nutr 56(3):1303–1316CrossRefPubMed

Kubatka P, Uramova S, Kello M, Kajo K, Kruzliak P, Mojzis J, Vybohova D, Adamkov M, Jasek K, Lasabova Z, Zubor P, Fialova S, Dokupilova S, Solar P, Pec M, Adamicova K, Danko J, Adamek M, Busselberg D (2017b) Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. J Cell Mol Med 21(11):2837–2851CrossRefPubMedPubMedCentral

Labelle M, Hynes RO (2012) The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2(12):1091–1099. https://doi.org/10.1158/2159-8290.CD-12-0329 (Epub 2012 Nov 19) CrossRefPubMedPubMedCentral

Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168(4):670–691. https://doi.org/10.1016/j.cell.2016.11.037 CrossRefPubMedPubMedCentral

Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178–196. https://doi.org/10.1038/nrm3758 CrossRefPubMedPubMedCentral

Lan L, Luo Y, Cui D, Shi BY, Deng W, Huo LL, Chen HL, Zhang GY, Deng LL (2013a) Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 43(1):113–120. https://doi.org/10.3892/ijo.2013.1913 (Epub 2013 Apr 22) CrossRefPubMed

Lan L, Luo Y, Cui D, Shi BY, Deng W, Huo LL, Chen HL, Zhang GY, Deng LL (2013b) Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 43:113–120. https://doi.org/10.3892/ijo.2013.1913 CrossRefPubMed

Lee CS, Cho HJ, Jeong YJ, Shin JM, Park KK, Park YY, Bae YS, Chung IK, Kim M, Kim CH, Jin F, Chang HW, Chang YC (2015) Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression. Oncol Rep 34(6):2901–2908. https://doi.org/10.3892/or.2015.4292 (Epub 2015 Sep 18) CrossRefPubMed

Li X, Yuan N, Lin L, Yin L, Qu Y (2018) Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer. Exp Ther Med 16(2):730–738. https://doi.org/10.3892/etm.2018.6274 (Epub 2018 Jun 8)CrossRefPubMedPubMedCentral

Lin Y, Xu T, Tian G, Cui M (2014) Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma. J Int Med Res 42(2):300–306. https://doi.org/10.1177/0300060513505268 (Epub 2014 Mar 4) CrossRefPubMed

Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafa R, Song J, Guo Z et al (2013) CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res 23:1446–1461CrossRefPubMedPubMedCentral

Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X, Lin L, Yao H, Su F, Li D, Zeng M, Song E (2015a) A cytoplasmic NF-kappaB interacting long noncoding RNA blocks IkappaB phosphorylation and suppresses breast cancer metastasis. Cancer cell 27:370–381. https://doi.org/10.1016/j.ccell.2015.02.004 CrossRefPubMed

Liu YZ, Yang CM, Chen JY, Liao JW, Hu ML (2015b) Alpha-carotene inhibits metastasis in Lewis lung carcinoma in vitro, and suppresses lung metastasis and tumor growth in combination with taxol in tumor xenografted C57BL/6 mice. J Nutr Biochem 26(6):607–615. https://doi.org/10.1016/j.jnutbio.2014.12.012 (Epub 2015 Feb 14) CrossRefPubMed

Liu B, Wei G, Shi J, Jin J, Shen T, Ni T, Shen WH, Yu Y, Dong A (2016) SET DOMAIN GROUP 708, a histone H3 lysine 36-specific methyltransferase, controls flowering time in rice (Oryza sativa). New Phytol 210(2):577–588. https://doi.org/10.1111/nph.13768 (Epub 2015 Dec 7) CrossRefPubMed

Liu L, Li W, Liu Q (2014a Nov-Dec) Recent development of antifouling polymers: structure, evaluation, and biomedical applications in nano/micro-structures. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6(6):599–614. https://doi.org/10.1002/wnan.1278 (Epub 2014 Jun 2) CrossRefPubMed

Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT (2014b) JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol 44(5):1643–1651. https://doi.org/10.3892/ijo.2014.2310 (Epub 2014 Feb 21) CrossRefPubMed

Liu W, Vivian CJ, Brinker AE, Hampton KR, Lianidou E, Welch DR (2014c) Microenvironmental influences on metastasis suppressor expression and function during a metastatic cell’s journey. Cancer Microenviron 7(3):117–131. https://doi.org/10.1007/s12307-014-0148-4 (Epub 2014 Jun 18) CrossRefPubMedPubMedCentral

Liu L, Tang Y, Gao C, Li Y, Chen S, Xiong T, Li J, Du M, Gong Z, Chen H et al (2014d) Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf B Biointerfaces 1:125–131CrossRef

Logan J, Bourassa MW (2018) The rationale for a role for diet and nutrition in the prevention and treatment of cancer. Eur J Cancer Prev 27(4):406–410. https://doi.org/10.1097/CEJ.0000000000000427 CrossRefPubMed

Long H, Xiang T, Qi W, Huang J, Chen J, He L, Liang Z, Guo B, Li Y, Xie R (2015) Zhu, B. CD133 + ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget 6:5846–5859PubMedPubMedCentral

Lu Y, Li F, Xu T, Sun J (2017) Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling. Int J Mol Med 39(4):993–1000. https://doi.org/10.3892/ijmm.2017.2895 (Epub 2017 Feb 17) CrossRefPubMed

Lubecka K, Kurzava L, Flower K, Buvala H, Zhang H, Teegarden D, Camarillo I, Suderman M, Kuang S, Andrisani O, Flanagan JM, Stefanska B (2016) Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Carcinogenesis 37(7):656–668. https://doi.org/10.1093/carcin/bgw048 (Epub 2016 Apr 28) CrossRefPubMedPubMedCentral

Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM (2001a) Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 61(14):5491–5498PubMed

Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM (2001b) Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 61:5491–5498PubMed

Ma XL, Xiao ZL, Liu L, Liu XX, Nie W, Li P, Chen NY, Wei YQ (2012a) Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev 13(4):1137–1144CrossRefPubMed

Ma XL, Xiao ZL, Liu L, Liu XX, Nie W, Li P, Chen NY, Wei YQ (2012b) Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev 13:1137–1144CrossRefPubMed

Maj E, Papiernik D, Wietrzyk J (2016) Antiangiogenic cancer treatment: the great discovery and greater complexity (Review). Int J Oncol 49(5):1773–1784. https://doi.org/10.3892/ijo.2016.3709 (Epub 2016 Sep 26) CrossRefPubMedPubMedCentral

Majumdar D, Jung KH, Zhang H, Nannapaneni S, Wang X, Amin AR, Chen Z, Chen ZG, Shin DM (2014) Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prev Res (Phila) 7(1):65–73. https://doi.org/10.1158/1940-6207.CAPR-13-0230 CrossRef

Mallini P, Lennard T, Kirby J, Meeson A (2014) Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev 40:341–348. https://doi.org/10.1016/j.ctrv.2013.09.008 CrossRefPubMed

Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715. https://doi.org/10.1016/j.cell.2008.03.027 CrossRefPubMedPubMedCentral

Massagué J, Obenauf AC (2016) Metastatic colonization by circulating tumour cells. Nature 529(7586):298–306. https://doi.org/10.1038/nature17038 CrossRefPubMedPubMedCentral

Miao JW, Liu LJ, Huang J (2014) Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Int J Oncol 45(1):165–176. https://doi.org/10.3892/ijo.2014.2422 (Epub 2014 May 6) CrossRefPubMed

Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP, Langmuir V, Rugo HS (2005) Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 23(4):792–799CrossRefPubMed

Mishra AP, Saklani S, Salehi B, Parcha V, Sharifi-Rad M, Milella L, Iriti M, Sharifi-Rad J, Srivastava M (2018) Satyrium nepalense, a high altitude medicinal orchid of Indian Himalayan region: chemical profile and biological activities of tuber extracts. Cell Mol Biol (Noisy-le-grand) 64(8):35–43CrossRef

Mitra A, Mishra L, Li SEMT (2015) CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 6:10697–10711CrossRefPubMedPubMedCentral

Moosavi MA, Haghi A, Rahmati M, Taniguchi H, Mocan A, Echeverría J, Gupta VK, Tzvetkov NT, Atanasov AG (2018) Phytochemicals as potent modulators of autophagy for cancer therapy. Cancer Lett 424:46–69. https://doi.org/10.1016/j.canlet.2018.02.030 (Epub 2018 Feb 21) CrossRefPubMed

Morata-Tarifa C, Jiménez G, García MA, Entrena JM, Griñán-Lisón C, Aguilera M, Picon-Ruiz M, Marchal JA (2016) Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells. Sci Rep 6:18772. https://doi.org/10.1038/srep18772 CrossRefPubMedPubMedCentral

Nabavi SF, Atanasov AG, Khan H, Barreca D, Trombetta D, Testai L, Sureda A, Tejada S, Vacca RA, Pittalà V, Gulei D, Berindan-Neagoe I, Shirooie S, Nabavi SM (2018) Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials. Cancer Lett 434:101–113. https://doi.org/10.1016/j.canlet.2018.07.018 CrossRefPubMed

Naito T, Tanaka F, Ono A, Yoneda K, Takahashi T, Murakami H, Nakamura Y, Tsuya A, Kenmotsu H, Shukuya T, Kaira K, Koh Y, Endo M, Hasegawa S, Yamamoto N (2012) Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J Thorac Oncol 7:512–519. https://doi.org/10.1097/JTO.0b013e31823f125d CrossRefPubMed

Neves AR, Martins S, Segundo MA, Reis S (2016) Nanoscale delivery of resveratrol towards enhancement of supplements and nutraceuticals. Nutrients 8:131. https://doi.org/10.3390/nu8030131 CrossRefPubMedPubMedCentral

Ng JM, Yu J (2015) Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci 16(2):2472–2496. https://doi.org/10.3390/ijms16022472 CrossRefPubMedPubMedCentral

Nguyen LT, Song YW, Cho SK (2016) Baicalein inhibits epithelial to mesenchymal transition via downregulation of Cyr61 and LOXL-2 in MDA-MB231 breast cancer cells. Mol Cells 39(12):909–914. https://doi.org/10.14348/molcells.2016.0243 (Epub 2016 Dec 23) CrossRefPubMedPubMedCentral

Nishida N, Yano H, Nishida T, Kamura T, Kojiro M (2006) Angiogenesis in cancer. Vasc Health Risk Manag 2(3):213–219CrossRefPubMedPubMedCentral

Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22:709–724. https://doi.org/10.1016/j.ccr.2012.10.012 CrossRefPubMed

Ombrato L, Malanchi I (2014) The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog 19:349–361CrossRefPubMed

Ou H, Li Y, Kang M (2014) Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene. PLoS One 9(11):e109929. https://doi.org/10.1371/journal.pone.0109929 (eCollection 2014) CrossRefPubMedPubMedCentral

Palomeras S, Ruiz-Martínez S, Puig T (2018) Targeting breast cancer stem cells to overcome treatment resistance. Molecules. https://doi.org/10.3390/molecules23092193 CrossRefPubMedPubMedCentral

Paoletti C, Hayes DF (2016) Circulating tumor cells. Adv Exp Med Biol 882:235–258CrossRefPubMed

Parbin S, Kar S, Shilpi A, Sengupta D, Deb M, Rath SK, Patra SK (2014) Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer. J Histochem Cytochem 62(1):11–33. https://doi.org/10.1369/0022155413506582 (Epub 2013 Sep 18)CrossRefPubMedPubMedCentral

Parvani JG, Gujrati MD, Mack MA, Schiemann WP, Lu ZR (2015) Silencing β3 integrin by targeted ECO/siRNA nanoparticles inhibits EMT and metastasis of triple-negative breast cancer. Cancer Res 75(11):2316–2325. https://doi.org/10.1158/0008-5472.CAN-14-3485 CrossRefPubMedPubMedCentral

Pereira LP, Silva P, Duarte M, Rodrigues L, Duarte CM, Albuquerque C, Serra AT (2017) Targeting colorectal cancer proliferation, stemness and metastatic potential using brassicaceae extracts enriched in isothiocyanates: a 3D cell model-based study. Nutrients. https://doi.org/10.3390/nu9040368 CrossRefPubMedPubMedCentral

Phi LTH, Sari IN, Yang YG, Lee SH, Jun N, Kim KS, Lee YK, Kwon HY (2018) Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int 2018:5416923. https://doi.org/10.1155/2018/5416923 (eCollection 2018) CrossRefPubMedPubMedCentral

Pignatelli M, Vilella AJ, Muffato M, Gordon L, White S, Flicek P, Herrero J (2016) ncRNA orthologies in the vertebrate lineage. Database (Oxford). https://doi.org/10.1093/database/bav127 (Print 2016) CrossRef

Pistollato F, Giampieri F, Battino M (2015) The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment. Food Chem Toxicol 75:58–70. https://doi.org/10.1016/j.fct.2014.11.004 CrossRefPubMed

Polivka J Jr, Kralickova M, Polivka J Jr, Kaiser C, Kuhn W, Golubnitschaja O (2017) Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J 8(2):119–127CrossRefPubMedPubMedCentral

Pollom EL, Deng L, Pai RK, Brown JM, Giaccia A, Loo BW Jr, Shultz DB, Le QT, Koong AC, Chang DT (2015) Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 92(3):568–576. https://doi.org/10.1016/j.ijrobp.2015.02.016 CrossRefPubMedPubMedCentral

Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 4:64. https://doi.org/10.3389/fonc.2014.00064 CrossRefPubMedPubMedCentral

Prado SBRD, Ferreira GF, Harazono Y, Shiga TM, Raz A, Carpita NC, Fabi JP (2017) Ripening-induced chemical modifications of papaya pectin inhibit cancer cell proliferation. Sci Rep 7(1):16564. https://doi.org/10.1038/s41598-017-16709-3 CrossRefPubMedPubMedCentral

Prakash Mishra A, Sharifi-Rad M, Shariati MA, Mabkhot YN, Al-Showiman SS, Rauf A, Salehi B, Župunski M, Sharifi-Rad M, Gusain P, Sharifi-Rad J, Suleria HAR, Iriti M (2018) Bioactive compounds and health benefits of edible Rumex species—a review. Cell Mol Biol (Noisy-le-grand) 64(8):27–34CrossRef

Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M et al (2013) The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 45:1392–1398CrossRefPubMedPubMedCentral

Pudenz M, Roth K, Gerhauser C (2014) Impact of soy isoflavones on the epigenome in cancer prevention. Nutrients 6(10):4218–4272. https://doi.org/10.3390/nu6104218 CrossRefPubMedPubMedCentral

Qian X, Tan C, Yang B, Wang F, Ge Y, Guan Z, Cai J (2017) Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest. Dis Esophagus 30(6):1–7. https://doi.org/10.1093/dote/dox027 CrossRefPubMed

Qian YY, Liu ZS, Yan HJ, Yuan YF, Levenson AS, Li K (2018) Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma. Biomed Pharmacother 101:852–859. https://doi.org/10.1016/j.biopha.2018.03.022 (Epub 2018 Mar 22) CrossRefPubMed

Ramaswamy B, Elias AD, Kelbick NT, Dodley A, Morrow M, Hauger M, Allen J, Rhoades C, Kendra K, Chen HX, Eckhardt SG, Shapiro CL (2006) Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients. Clin Cancer Res 12(10):3124–3129CrossRefPubMed

Reymond N, d’Água BB, Ridley AJ (2013) Crossing the endothelial barrier during metastasis. Nat Rev Cancer 13(12):858–870. https://doi.org/10.1038/nrc3628 CrossRefPubMed

Sak K (2012) Chemotherapy and dietary phytochemical agents. Chemother Res Pract 2012:282570. https://doi.org/10.1155/2012/282570 (Epub 2012 Dec 20) CrossRefPubMedPubMedCentral

Salehi B, Varoni EM, Sharifi-Rad M, Rajabi S, Zucca P, Iriti M, Sharifi-Rad J (2019) Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis. Phytomedicine 55:125–136. https://doi.org/10.1016/j.phymed.2018.07.001 CrossRefPubMed

Salehi B, Zucca P, Sharifi-Rad M, Pezzani R, Rajabi S, Setzer WN, Varoni EM, Iriti M, Kobarfard F, Sharifi-Rad J (2018) Phytotherapeutics in cancer invasion and metastasis. Phytother Res 32(8):1425–1449. https://doi.org/10.1002/ptr.6087 (Epub 2018 Apr 19) CrossRefPubMed

Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 6(4):a018713. https://doi.org/10.1101/cshperspect.a018713 CrossRefPubMedPubMedCentral

Shang D, Li Z, Zhu Z, Chen H, Zhao L, Wang X, Chen Y (2015) Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway. Oncol Rep 33(4):2077–2085. https://doi.org/10.3892/or.2015.3786 (Epub 2015 Feb 5) CrossRefPubMed

Shankar E, Kanwal R, Candamo M, Gupta S (2016) Dietary phytochemicals as epigenetic modifiers in cancer: promise and challenges. Semin Cancer Biol 40–41:82–99. https://doi.org/10.1016/j.semcancer.2016.04.002 (Epub 2016 Apr 23) CrossRefPubMedPubMedCentral

Sharifi-Rad M, Fokou PVT, Sharopov F, Martorell M, Ademiluyi AO, Rajkovic J, Salehi B, Martins N, Iriti M, Sharifi-Rad J (2018a) Antiulcer agents: from plant extracts to phytochemicals in healing promotion. Molecules. https://doi.org/10.3390/molecules23071751 CrossRefPubMedPubMedCentral

Sharifi-Rad M, Nazaruk J, Polito L, Morais-Braga MFB, Rocha JE, Coutinho HDM, Salehi B, Tabanelli G, Montanari C, Del Mar Contreras M, Yousaf Z, Setzer WN, Verma DR, Martorell M, Sureda A, Sharifi-Rad J (2018b) Matricaria genus as a source of antimicrobial agents: from farm to pharmacy and foodapplications. Microbiol Res 215:76–88. https://doi.org/10.1016/j.micres.2018.06.010 (Epub 2018 Jun 25) CrossRefPubMed

Shen A, Lin W, Chen Y, Liu L, Chen H, Zhuang Q, Lin J, Sferra TJ, Peng J (2015) Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network. Int J Oncol 46(2):685–690. https://doi.org/10.3892/ijo.2014.2772 (Epub 2014 Nov 24) CrossRefPubMed

Shi SJ, Wang LJ, Yu B, Li YH, Jin Y, Bai XZ (2015) LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget 6:11652–11663PubMedPubMedCentral

Siddiqui IA, Sanna V (2016) Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. Mol Nutr Food Res 60(6):1330–1341. https://doi.org/10.1002/mnfr.201600035 (Epub 2016 Apr 4) CrossRefPubMed

Singh BN, Singh HB, Singh A, Naqvi AH, Singh BR (2014) Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev 33(1):41–85. https://doi.org/10.1007/s10555-013-9457-1 CrossRefPubMed

Smith HA, Kang Y (2013a) The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 91(4):411–429. https://doi.org/10.1007/s00109-013-1021-5 (Epub 2013 Mar 21) CrossRef

Smith HA, Kang Y (2013b) The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 91:411–429. https://doi.org/10.1007/s00109-013-1021-5 CrossRef

Sorensen KP, Thomassen M, Tan Q, Bak M, Cold S, Burton M, Larsen MJ, Kruse TA (2013) Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treatm 142:529–536. https://doi.org/10.1007/s10549-013-2776-7 CrossRef

Sun L, Fang J (2016) Epigenetic regulation of epithelial-mesenchymal transition. Cell Mol Life Sci 73(23):4493–4515 (Epub 2016 Jul 8) CrossRefPubMedPubMedCentral

Sun YF, Wink M (2014 Jul-Aug) Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine 21(8–9):1110–1119. https://doi.org/10.1016/j.phymed.2014.04.029 (Epub 2014 May 22) CrossRefPubMed

Szejk M, Kołodziejczyk-Czepas J, Żbikowska HM (2016) Radioprotectors in radiotherapy—advances in the potential application of phytochemicals. Postepy Hig Med Dosw (Online) 70:722–734. https://doi.org/10.5604/17322693.1208039 CrossRef

Tan Y, Wei X, Zhang W, Wang X, Wang K, Du B, Xiao J (2017) Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1. Oncol Rep 37(3):1833–1841. https://doi.org/10.3892/or.2017.5413 (Epub 2017 Jan 30) CrossRefPubMed

Vuong T, Mallet JF, Ouzounova M, Rahbar S, Hernandez-Vargas H, Herceg Z, Matar C (2016) Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation. J Transl Med 14:13. https://doi.org/10.1186/s12967-016-0770-7 CrossRefPubMedPubMedCentral

Wang DX, Zou YJ, Zhuang XB, Chen SX, Lin Y, Li WL, Lin JJ, Lin ZQ (2017a) Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways. Acta Pharmacol Sin 38(2):241–251. https://doi.org/10.1038/aps.2016.122 (Epub 2016 Nov 28) CrossRefPubMed

Wang J, Kang M, Wen Q, Qin YT, Wei ZX, Xiao JJ, Wang RS (2017b) Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT. Oncol Rep 37(4):2425–2432. https://doi.org/10.3892/or.2017.5499 (Epub 2017 Mar 13) CrossRefPubMed

Wang W, Du Z, Nimiya Y, Sukamtoh E, Kim D, Zhang G (2016) Allicin inhibits lymphangiogenesis through suppressing activation of vascular endothelial growth factor (VEGF) receptor. J Nutr Biochem 29:83–89. https://doi.org/10.1016/j.jnutbio.2015.11.004 (Epub 2015 Nov 24) CrossRefPubMed

Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD (2015a) Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S224–S243. https://doi.org/10.1016/j.semcancer.2015.01.001 (Epub 2015 Jan 16) CrossRefPubMedPubMedCentral

Wang Z, Cui K, Xue Y, Tong F, Li S (2015b) Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Med Oncol 32:164. https://doi.org/10.1007/s12032-015-0579-x CrossRefPubMed

Wei J, Yu G, Shao G, Sun A, Chen M, Yang W, Lin Q (2016) CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma. Oncotarget 7(21):31067–31078. https://doi.org/10.18632/oncotarget.8845 CrossRefPubMedPubMedCentral

Wei Z, Shan Y, Tao L, Liu Y, Zhu Z, Liu Z, Wu Y, Chen W, Wang A, Lu Y (2017a) Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis. Mol Carcinog 56(10):2317–2331. https://doi.org/10.1002/mc.22686 (Epub 2017 Jul 6) CrossRefPubMed

Wei Z, Shan Y, Tao L, Liu Y, Zhu Z, Liu Z, Wu Y, Chen W, Wang A, Lu Y (2017b) Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis. Mol Carcinog 56(10):2317–2331. https://doi.org/10.1002/mc.22686 (Epub 2017 Jul 6) CrossRefPubMed

Wen C, Huang L, Chen J, Lin M, Li W, Lu B, Rutnam ZJ, Iwamoto A, Wang Z, Yang X, Liu H (2015) Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells. Int J Oncol 47(5):1663–1671. https://doi.org/10.3892/ijo.2015.3166 (Epub 2015 Sep 15) CrossRefPubMedPubMedCentral

Wu C, Qiu S, Liu P, Ge Y, Gao X (2018) Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. J Ethnopharmacol 211:89–100. https://doi.org/10.1016/j.jep.2017.09.033 (Epub 2017 Sep 27) CrossRefPubMed

Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt Mde C (2016a) Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Sci Rep 6:20210. https://doi.org/10.1038/srep20210 CrossRefPubMedPubMedCentral

Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt MC (2016b) Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Sci Rep 6:20210. https://doi.org/10.1038/srep20210 CrossRefPubMedPubMedCentral

Xing Z, Lin A, Li C, Liang K, Wang S, Liu Y, Park PK, Qin L, Wei Y, Hawke DH et al (2014) lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 159:1110–1125CrossRefPubMedPubMedCentral

Yan Y, Li Z, Xu X, Chen C, Wei W, Fan M, Chen X, Li JJ, Wang Y, Huang J (2016) All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy. BMC Compl Altern Med 16:113. https://doi.org/10.1186/s12906-016-1088-y CrossRef

Yang FQ, Liu M, Li W, Che JP, Wang GC, Zheng JH (2015a) Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Mol Med Rep 11(2):1085–1092. https://doi.org/10.3892/mmr.2014.2813 (Epub 2014 Oct 29) CrossRefPubMed

Yang SF, Lee WJ, Tan P, Tang CH, Hsiao M, Hsieh FK, Chien MH (2015b) Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas. Oncotarget 6(5):2736–2753PubMed

Yang X, Belosay A, Hartman JA, Song H, Zhang Y, Wang W, Doerge DR, Helferich WG (2015c) Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors. Clin Exp Metastasis 32(4):323–333. https://doi.org/10.1007/s10585-015-9709-2 (Epub 2015 Mar 8) CrossRefPubMedPubMedCentral

Yang Y, Jiang M, Hu J, Lv X, Yu L, Qian X, Liu B (2015d) Enhancement of radiation effects by ursolic acid in BGC-823 human adenocarcinoma gastric cancer cell line. PLoS One 10(7):e0133169. https://doi.org/10.1371/journal.pone.0133169 (eCollection 2015) CrossRefPubMedPubMedCentral

Yang H, Salz T, Zajac-Kaye M, Liao D, Huang S, Qiu Y (2014) Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators. FASEB J 28(10):4265–4279. https://doi.org/10.1096/fj.14-250654 (Epub 2014 Jun 19) CrossRefPubMedPubMedCentral

Yang M, Yang Y, Cui H, Guan Z, Yang Y, Zhang H, Chen X, Zhu H, Yang X, Cai J, Cheng H, Sun X. The natural compound gambogic acid radiosensitizes nasopharyngeal carcinoma cells under hypoxic conditions. Tumori. 2016 Mar-Apr;102(2):135–43. https://doi.org/10.5301/tj.5000411 (Epub 2015 Sep 10)

Yano M, Yasuda M, Sakaki M, Nagata K, Fujino T, Arai E, Hasebe T, Miyazawa M, Miyazawa M, Ogane N, Hasegawa K, Narahara H (2018) Association of histone deacetylase expression with histology and prognosis of ovarian cancer. Oncol Lett 15(3):3524–3531. https://doi.org/10.3892/ol.2018.7726 (Epub 2018 Jan 4) CrossRefPubMedPubMedCentral

Yao M, Yuan B, Wang X, Sato A, Sakuma K, Kaneko K, Komuro H, Okazaki A, Hayashi H, Toyoda H, Pei X, Hu X, Hirano T, Takagi N (2017) Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7. Int J Oncol 51(2):587–598. https://doi.org/10.3892/ijo.2017.4052 (Epub 2017 Jun 23) CrossRefPubMed

Ye L, Jia Y, Ji KE, Sanders AJ, Xue K, Ji J, Mason MD, Jiang WG (2015) Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncol Lett 10(3):1240–1250 (Epub 2015 Jul 6) CrossRefPubMedPubMedCentral

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM (2013a) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584. https://doi.org/10.1126/science.1228522 CrossRefPubMedPubMedCentral

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S (2013b) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580–584. https://doi.org/10.1126/science.1228522 CrossRefPubMedPubMedCentral

Zhang C, Shu L, Kim H, Khor TO, Wu R, Li W, Kong AN (2016) Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194. Mol Nutr Food Res 60(6):1427–1436. https://doi.org/10.1002/mnfr.201500918 (Epub 2016 May 17) CrossRefPubMedPubMedCentral

Zhang J, Wang L, Fai Chan H, Xie W, Chen S, He C, Wang Y, Chen M (2017a) Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells. Sci Rep 7:46057. https://doi.org/10.1038/srep46057 CrossRefPubMedPubMedCentral

Zhang Y, Lv Y, Niu Y, Su H, Feng A (2017b) Role of circulating tumor cell (CTC) monitoring in evaluating prognosis of triple-negative breast cancer patients in China. Med Sci Monit 23:3071–3079CrossRefPubMedPubMedCentral

Zhang L, Liu Z, Ma W, Wang B (2013) The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer. J Cancer Res Ther 9(Suppl 2):S86–S91. https://doi.org/10.4103/0973-1482.119113 CrossRefPubMed

Zhang X, Guo Q, Chen J, Chen Z (2015) Quercetin enhances cisplatin sensitivity of human osteosarcoma cells by modulating microRNA-217-KRAS axis. Mol Cells 38(7):638–642. https://doi.org/10.14348/molcells.2015.0037 (Epub 2015 Jun 10) CrossRefPubMedPubMedCentral

Zhao H, Yu Z, Zhao L, He M, Ren J, Wu H, Chen Q, Yao W, Wei M (2016) HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J Clin Oncol 46(10):893–902 (Epub 2016 Jul 18) CrossRefPubMed

Zhao J (2016) Cancer stem cells and chemoresistance: The smartest survives the raid. Pharmacol Ther 160:145–158. https://doi.org/10.1016/j.pharmthera.2016.02.008 (Epub 2016 Feb 17) CrossRefPubMedPubMedCentral

Zhao Y, Yao J, Wu XP, Zhao L, Zhou YX, Zhang Y, You QD, Guo QL, Lu N (2015) Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway. Mol Carcinog 54(Suppl 1):E81–E93. https://doi.org/10.1002/mc.22182 (Epub 2014 Jun 29) CrossRefPubMed

Zheng HC (2017) The molecular mechanisms of chemoresistance in cancers. Oncotarget 8(35):59950–59964. https://doi.org/10.18632/oncotarget.19048 (eCollection 2017 Aug 29) CrossRefPubMedPubMedCentral

Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R (2015) Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527:525–530. https://doi.org/10.1038/nature16064 CrossRefPubMedPubMedCentral

Zhou H, Huang S (2011) Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci 12(1):30–42CrossRefPubMedPubMedCentral

Zhou R, Xu L, Ye M, Liao M, Du H, Chen H (2014) Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Horm Metab Res 46(11):753–760. https://doi.org/10.1055/s-0034-1376977 (Epub 2014 Jun 30) CrossRefPubMed

Zhou D, Kannappan V, Chen X, Li J, Leng X, Zhang J, Xuan S (2016) RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma. Exp Mol Med 48:e238CrossRefPubMedPubMedCentral

Zhu Y, Fang J, Wang H, Fei M, Tang T, Liu K, Niu W, Zhou Y (2018) Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca2+-dependent pathway. Drug Des Devel Ther 12:3247–3261. https://doi.org/10.2147/DDDT.S176403 (eCollection 2018) CrossRefPubMedPubMedCentral

Titel: Controlling metastatic cancer: the role of phytochemicals in cell signaling
verfasst von: Andrea Kapinova
Peter Kubatka
Alena Liskova
Denis Baranenko
Peter Kruzliak
Milan Matta
Dietrich Büsselberg
Bibiana Malicherova
Anthony Zulli
Taeg Kyu Kwon
Eva Jezkova
Dana Blahutova
Pavol Zubor
Jan Danko
Publikationsdatum: 22.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2019
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-019-02892-5

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Controlling metastatic cancer: the role of phytochemicals in cell signaling

Abstract

Purpose

Results

Conclusions

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Abstract

Purpose

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma

Disparity in age at lung cancer diagnosis between current and former smokers

CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer

The application of ApcMin/+ mouse model in colorectal tumor researches

Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma

Heart myxoma develops oncogenic and metastatic phenotype

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie